Alexium Presented at the ASX Spotlight in New York City on March 3rd


PERTH, AUSTRALIA and GREER, SC--(Marketwired - Mar 7, 2016) - Alexium International Group Limited (Alexium) (ASX: AJX) (OTCQX: AXXIY) is pleased to announce Alexium -- in conjunction with our corporate advisors Moelis & Company -- presented to institutional investors, home funds and standard funds at the Australian Securities Exchange (ASX) conference "ASX Spotlight" in New York City on March 3rd. This unique conference provides participating companies with an efficient and resourceful way to reach the international investor market. During the conference, various institutional investors selected Alexium to meet 1 on 1 as they had an interest in the company and our efforts.

To view the full presentation, click here.

About Alexium

Alexium International Group Limited (ASX: AJX) (OTCQX: AXXIY) holds proprietary patent applications for a process developed initially by the U.S. Department of Defense, which allows for the surface modification and attachment of nano-particles or multiple chemical functional groups to surfaces or substrates to provide functions such as fire retardancy, water proofing, oil proofing, and anti-microbial treatments. Applications under development include but are not limited to textiles, paints, and packaging, glass and building materials. Alexium's fire retardant chemical treatment are currently marketed for different fabric markets under the Alexiflam™, Ascalon™, Nycolon™, Nuvalon™, and Polytron™, Omnitron™ and Bactron™ trademarks.

About Moelis & Company
Moelis & Company is a leading global independent investment bank that provides innovative strategic advice and solutions to a diverse client base, including corporations, governments and financial sponsors. Moelis & Company was this year's ASX Spotlight's Platinum Sponsor.
http://www.moelis.com/SitePages/Home.aspx

Contact Information:

U.S Contacts:
Nick Clark
Chief Executive Officer
nclark@alexiuminternational.com
U.S.: +1 864.991.6687

Bradi Dobson
Marketing Specialist
BDobson@alexiuminternational.com

U.S. R&D Center:
8 Distribution Court
Greer, SC 29650
T: +1 864.416.1060
F: +1 864.752.6465

U.S. Corporate Office:
148 Milestone Way
Greenville, SC 29615
T: +1 864.603.1165
F: +1 864.752.6465

ABN: 91 064 820 408
ASX: AJX